National Bank of Canada’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
National Bank of Canada's ARKG Position: Q1 2026 in Review
National Bank of Canada reduced its ARK Genomic Revolution ETF (ARKG) stake by 1.6% in Q1 2026, selling an estimated $1.46K and leaving 3,052 shares worth $80.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.
National Bank of Canada first reported a position in ARKG in Q4 2021 and has held it in 18 quarters since. The position peaked at $28.4M in Q4 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- National Bank of Canada held 3,052 shares of ARK Genomic Revolution ETF worth $80.6K as of Q1 2026.
- National Bank of Canada sold 50 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.46K.
- ARK Genomic Revolution ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1842 holding.
- National Bank of Canada first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's ARK Genomic Revolution ETF position peaked at $28.4M in Q4 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.